QUOTE AND NEWS
Forbes  Apr 1  Comment 
Chris Garabedian, the chief executive who turned Cambridge, Mass.-based Sarepta Therapeutics from a floundering antiviral company called AVI Biopharma into an investor darling, resigned today, according to a press release from the company....
Benzinga  Nov 27  Comment 
Dominick & Dominick initiated coverage on Sarepta Therapeutics (NASDAQ: SRPT) with a Market Perform rating. Dominick & Dominick noted, "Sarepta Therapeutics, formerly known as AVI Biopharma, is developing RNA-based medicines that treat...
Phil’s Stock World  Aug 5  Comment 
Courtesy of Benzinga. var ads_url = ""; document.write(ads_url); Autobytel Inc. (Nasdaq: ABTL) today announced that the previously announced 1-for-5 reverse split of the Company's common stock, $0.001 par value per share, took...
Phil’s Stock World  Aug 5  Comment 
Courtesy of Benzinga. AVI BioPharma, Inc. (NASDAQ: AVII) today announced that it has changed its name to Sarepta Therapeutics, Inc. ("the Company") and has effected a one-for-six reverse stock split. The name change and reverse stock...
Phil’s Stock World  Jul 16  Comment 
Courtesy of Benzinga. Autobytel Inc. (Nasdaq: ABTL) today announced that the previously announced 1-for-5 reverse split of the Company's common stock, $0.001 par value per share, took effect after the close of trading on the NASDAQ...
Phil’s Stock World  Jul 16  Comment 
Courtesy of Benzinga. AVI BioPharma, Inc. (NASDAQ: AVII) today announced that it has changed its name to Sarepta Therapeutics, Inc. ("the Company") and has effected a one-for-six reverse stock split. The name change and reverse stock...
Marketwire  Jul 12  Comment 
NEW YORK, NY -- (Marketwire) -- 07/12/12 -- Despite the recent economic slowdown, the Biotech Industry has been home to some of the strongest performers in the market in 2012. The SPDR S&P Biotech ETF (XBI) and the First Trust NYSE Arca Biotech Index
Marketwire  Jul 12  Comment 
BOTHELL, WA -- (Marketwire) -- 07/12/12 -- AVI BioPharma, Inc. (NASDAQ: AVII) today announced that it has changed its name to Sarepta Therapeutics, Inc. ("the Company") and has effected a one-for-six reverse stock split. The name change and reverse
Marketwire  Jul 6  Comment 
BOTHELL, WA -- (Marketwire) -- 07/06/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced today that it is scheduled to present at the Seventh Annual JMP Securities Healthcare Conference in New York, NY on
StreetInsider.com  Jun 26  Comment 
Omeros (Nasdaq: OMER) 14.6% LOWER; announces a public stock offering of common shares. The company will grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock to cover...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki